# Study in COvid-19 Patients With iveRmectin (CORVETTE-01)

> **NCT04703205** · PHASE2 · UNKNOWN · sponsor: **Kitasato University** · enrollment: 214 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin 3 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04703205
- **Lead sponsor:** Kitasato University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-16
- **Primary completion:** 2021-10-22
- **Final completion:** 2022-05-31
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2022-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04703205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04703205, "Study in COvid-19 Patients With iveRmectin (CORVETTE-01)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04703205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*